Learn more at the Community Webinar on Sept. 5, 2024, at 8:00PM(ET)
We encourage anyone with a connection to CAH to attend our community webinar on September 5, 2024 at 8:00PM(ET) to learn more about the upcoming Externally Led Patient-Focused Drug Development (EL-PFDD) Meeting that is taking place this October.
To receive the Community Webinar link, you must register for the virtual EL-PFDD meeting.
What is Patient-Focused Drug Development?
Patient-Focused Drug Development (PFDD) is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation.
FDA’s Role in Medical Product Development
One of the FDA’s missions is to protect and promote public health by evaluating the safety and effectiveness of new drugs, biologics, and devices. FDA does not develop drugs nor conduct clinical trials. FDA does, however, play a constructive role in guiding, helping, or evaluating at some stages of the pre-clinical, translational, and clinical development at work.
Audience
The key participants in PFDD meetings are patients, patient representatives, patient advocates, caregivers, loved ones, and anyone with a lived experience with the disease or condition. While patients and caregivers share their perspectives, key stakeholders are in listening mode as a part of the audience. This includes:
It is important for all of these stakeholders to hear patient input as it may inform drug development. Aside from providing initial remarks from the FDA perspective, FDA staff participate as listeners in EL-PFDD meetings. The FA has been in support in the planning of this meeting.
Some host patient organizations choose to incorporate PFDD-style sessions as part of their annual conferences, scientific workshops, and other meetings. It is important to get patient input early in the drug development process.
CONTACT
2414 Morris Avenue, Ste 110
Union, NJ 07083
Phone: (908) 364-0272
Toll Free: (866) 227-3737
Fax: (908) 686-2019
contact@caresfoundation.org